Publications
Below is a list of research publications published in scientific journals by IDDO and WWARN and our research partners. Use the filters to explore the publications by research theme or by using our list of key words. If you cannot find a publication, please email info@iddo.org
A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India
Ahmad, S., Verma, R., Commons, R., Nitika, Singh-Phulgenda, S., Chhajed, R., Bharti, P., Behera, B., Naser, S., Pal, S., Ranjit, P., Baharia, R., Solanki, B., Upadhyay, K., Guerin, P., Sharma, A., Price, R., Rahi, M., & Thriemer, K. (2024). Trials, 25(1).
The burden of tuberculosis in Ho Chi Minh City, Vietnam: a spatial analysis of drug-susceptible and multi-drug resistant cases between 2020 and 2023
Spies, R., Hong, H., Trieu, P., Lan, L., Lan, K., Hue, N., Huong, N., Thao, T., Quang, N., Anh, T., Vinh, T., Dang, T., Phan, T., Nguyen, P., Van, L., Thwaites, G., Nguyen, T., Watson, J., & Walker, T. (2024). Emerging Infectious Diseases, 30(3), 499-509.
The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis.
Singh, S., Boyd, S., Schilling, W., Watson, J., Mukaka, M., & White, N. (2024). The Journal of Antimicrobial Chemotherapy, 79(5), 935-945.
Forensic investigation of falsified antimalarials using isotope ratio mass spectrometry: a pilot investigation
Newton, P., Chesson, L., Mayxay, M., Dondorp, A., Tabernero, P., Howa, J., & Cerling, T. (2024). Scientific Reports, 14(1).
Repurposing rapid diagnostic tests to detect falsified vaccines in supply chains
Bharucha, T., Gangadharan, B., Clarke, R., Gomez Fernandez, L., Yohan Arman, B., Walsby-tickle, J., Deats, M., Mosca, S., Lin, Q., Stokes, R., Dunachie, S., Merchant, H., Dubot-Peres, A., Caillet, C., McCullagh, J., Matousek, P., Zitzmann, N., & Newton, P. (2024). Vaccine.
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990–2019: a modelling study
Browne, A., Chipeta, M., Fell, F., Haines-Woodhouse, G., Kashef Hamadani, B., Kumaran, E., Robles Aguilar, G., McManigal, B., Ashley, E., Chansamouth, V., Basnyat, B., Dunachie, S., Henry, N., Karkey, A., Mayxay, M., Newton, P., Phommasone, K., Pokharel, S., Pollard, A., … Dolecek, C. (2024). Lancet Global Health, 12(3), e406 - e418.
Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
Watson, J., Commons, R., Tarning, J., Simpson, J., Llanos Cuentas, A., Lacerda, M., Green, J., Koh, G., Chu, C., Nosten, F., Price, R., Day, N., & White, N. (2024). ELife, 13.
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
Pukrittayakamee, S., Jittamala, P., Watson, J., Hanboonkunupakarn, B., Leungsinsiri, P., Poovorawan, K., Chotivanich, K., Bancone, G., Chu, C., Imwong, M., Day, N., Taylor, W., & White, N. (2024). ELife, 12.
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
Pukrittayakamee, S., Jittamala, P., Watson, J., Hanboonkunupakarn, B., Leungsinsiri, P., Poovorawan, K., Chotivanich, K., Bancone, G., Chu, C., Imwong, M., Day, N., Taylor, W., & White, N. (2024). ELife, 12.
Community-acquired Staphylococcus aureus bacteremia among people who inject drugs: a national cohort study in England, 2017–2020
McGuire, E., Collin, S., Brown, C., & Saito, M. (2024). Clinical Infectious Diseases, 78(6), 1443-1450.
Spatial analysis of drug-susceptible and multidrug-resistant cases of tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023
Spies, R., Hong, H., Trieu, P., Lan, L., Lan, K., Hue, N., Huong, N., Thao, T., Quang, N., Anh, T., Vinh, T., Ha, D., Dat, P., Hai, N., Van, L., Thwaites, G., Thuong, N., Watson, J., & Walker, T. (2024). Emerging Infectious Diseases, 30(3), 499-509.
Identification of Burkholderia cepacia strains that express a Burkholderia pseudomallei-like capsular polysaccharide
Burtnick, M., Dance, D., Vongsouvath, M., Newton, P., Dittrich, S., Sendouangphachanh, A., Woods, K., Davong, V., Kenna, D., Saiprom, N., Sengyee, S., Hantrakun, V., Wuthiekanun, V., Limmathurotsakul, D., Chantratita, N., & Brett, P. (2024). Microbiology Spectrum, 12(3).
Diagnosis of human leptospirosis: systematic review and meta-analysis of the diagnostic accuracy of the Leptospira microscopic agglutination test, PCR targeting Lfb1, and IgM ELISA to Leptospira fainei serovar Hurstbridge.
Valente, M., Bramugy, J., Keddie, S., Hopkins, H., Bassat, Q., Baerenbold, O., Bradley, J., Falconer, J., Keogh, R., Newton, P., Picardeau, M., & Crump, J. (2024). BMC Infectious Diseases, 24(1), 168.
Updating estimates of Plasmodium knowlesi malaria risk in response to changing land use patterns across Southeast Asia.
Tobin, R., Harrison, L., Tully, M., Lubis, I., Noviyanti, R., Anstey, N., Rajahram, G., Grigg, M., Flegg, J., Price, D., & Shearer, F. (2024). PLOS Neglected Tropical Diseases, 18(1), e0011570.
Implementing the WHO AWaRe antibiotic book guidance in lower-resource settings: the case of the Lao PDR
Chansamouth, V., Inlorkham, P., Keohavong, B., Bellingham, K., van Doorn, H., Mayxay, M., Newton, P., Turner, P., Day, N., & Ashley, E. (2024). JAC-Antimicrobial Resistance, 6(1).
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Luvira, V., Schilling, W., Jittamala, P., Watson, J., Boyd, S., Siripoon, T., Ngamprasertchai, T., Almeida, P., Ekkapongpisit, M., Cruz, C., Callery, J., Singh, S., Tuntipaiboontana, R., Kruabkontho, V., Ngernseng, T., Tubprasert, J., Abdad, M., Keayarsa, S., Madmanee, W., … White, N. (2024). BMC Infectious Disease, 24(1).
Lightweight transformers for clinical natural language processing
Rohanian, O., Nouriborji, M., Jauncey, H., Kouchaki, S., Nooralahzadeh, F., Clifton, L., Merson, L., & Clifton, D. (2024). Natural Language Engineering, 30(5), 887-914.
Clinical and laboratory profile of Expanded Dengue Syndrome: experience of 2019 outbreak from Dhaka, Bangladesh.
Hossain, Z., Chowdhury, F., Bari, M., Deb, S., Mallik, U., Aman, S., Haque, M., Ahmed, S., Mohammad, W., Bulbul, A., Hossain, M., Alam, M., Islam, M., Salma, U., Rahman, M., & Chowdhury, F. (2024). Journal of Vector Borne Diseases, 61(1), 123-128.
A time of decline: An eco-anthropological and ethnohistorical investigation of mpox in the Central African Republic.
Duda, R., Betoulet, J., Besombes, C., Mbrenga, F., Borzykh, Y., Nakouné, E., & Giles-Vernick, T. (2024). PLOS Global Public Health, 4(3), e0002937.
COVID-19 mass testing in adult social care in England
Chen, S., Creswell, R., Hounsell, R., Cantrell, L., Bajaj, S., Dahal, P., Tsui, L., Kolade, O., Amswych, M., Naidoo, R., Fowler, T., Hopkins, S., Stepniewska, K., Voysey, M., White, L., Shretta, R., & Lambert, B. (2024). In medRxiv.
Factors Affecting Integration of an Early Warning System for Antimalarial Drug Resistance within a Routine Surveillance System in a Pre-elimination Setting in Sub-Saharan Africa
Kagoro, F., Allen, E., Raman, J., Mabuza, A., Magagula, R., Kok, G., Malatje, G., Guerin, P., Dhorda, M., Maude, R., & Barnes, K. (2024). In medRxiv.
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak, P., Schilling, W., Jittamala, P., Boyd, S., Luvira, V., Siripoon, T., Ngamprasertchai, T., Batty, E., Singh, S., Kouhathong, J., Pagornrat, W., Khanthagan, P., Hanboonkunupakarn, B., Poovorawan, K., Mayxay, M., Chotivanich, K., Imwong, M., Pukrittayakamee, S., Ashley, E., … Watson, J. (2024). In medRxiv.
Modelling the within-host dynamics ofPlasmodium vivaxhypnozoite activation: an analysis of the SPf66 vaccine trial
Mehra, S., Nosten, F., Luxemburger, C., White, N., & Watson, J. (2024). In medRxiv.
Brief communications: changes in inflammatory biomarkers and lipid profiles after switching to long-acting cabotegravir plus rilpivirine.
Adachi, E., Saito, M., Otani, A., Koga, M., & Yotsuyanagi, H. (2024). AIDS Research and Therapy, 21(1), 1.
Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review
Wilson, J., Chowdhury, F., Hassan, S., Harriss, E., Alves, F., Musa, A., Dahal, P., Stepniewska, K., & Guerin, P. (2024, January 1).